Statins and Ezetimibe

Pre-clinicalUNKNOWN

1 views this week 0 watching💤 Quiet

Interest: 22/100

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Heterozigous Familial Hypercholesterolemia

Conditions

Heterozigous Familial Hypercholesterolemia

Trial Timeline

Apr 1, 2007 → —

NCT ID

NCT00475826

About Statins and Ezetimibe

Statins and Ezetimibe is a pre-clinical stage product being developed by Merck for Heterozigous Familial Hypercholesterolemia. The current trial status is unknown. This product is registered under clinical trial identifier NCT00475826. Target conditions include Heterozigous Familial Hypercholesterolemia.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00475826	Pre-clinical	UNKNOWN	Apr 1, 2007	—	Heterozigous Familial Hypercholesterolemia